Treatment of rheumatoid arthritisEMERY, Paul.BMJ. British medical journal (International ed.). 2006, Vol 332, Num 7534, pp 152-155, issn 0959-8146, 4 p.Article

Is It Time for a European Consensus on the Pharmacological Management of Early Rheumatoid Arthritis?EMERY, Paul.Journal of rheumatology. Supplement. 2002, Vol 29, issn 0380-0903, 44 p., SUP66Conference Proceedings

Evolving Concepts in the Treatment of Rheumatoid ArthritisEMERY, Paul.Journal of rheumatology. Supplement. 2001, Vol 28, Num 62, issn 0380-0903, 36 p.Conference Proceedings

Golimumab — a new tool in the armoury against inflammatory arthritisASH, Zoe; EMERY, Paul.Annals of medicine (Helsinki). 2011, Vol 43, Num 1-2, pp 133-141, issn 0785-3890, 9 p.Article

Rheumatoid arthritis : what has changed?VILLENEUVE, Edith; EMERY, Paul.Skeletal radiology. 2009, Vol 38, Num 2, pp 109-112, issn 0364-2348, 4 p.Article

Review of health economics modelling in rheumatoid arthritisEMERY, Paul.PharmacoEconomics (Auckland). 2004, Vol 22, Num 2, pp 55-69, issn 1170-7690, 15 p., SUPArticle

Cyclooxygenase-2 : A major therapeutic advance?EMERY, Paul.The American journal of medicine. 2001, Vol 110, Num 1A, pp 42S-45S, issn 0002-9343Conference Paper

The development of targeted therapies in rheumatoid arthritisVITAL, Edward M; EMERY, Paul.Journal of autoimmunity (Print). 2008, Vol 31, Num 3, pp 219-227, issn 0896-8411, 9 p.Article

Analgesic Effectiveness of Celecoxib and Diclofenac in Patients with Osteoarthritis of the Hip Requiring Joint Replacement Surgery : A 12-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Double-Dummy, Noninferiority StudyEMERY, Paul; KONCZ, Tamas; PAN, Sharon et al.Clinical therapeutics. 2008, Vol 30, Num 1, pp 70-83, issn 0149-2918, 14 p.Article

Gout related upper limb cellulitis: An ultrasound studyWAKEFIELD, Richard J; EMERY, Paul; PEASE, Colin et al.Journal of rheumatology. 2003, Vol 30, Num 2, pp 417-419, issn 0315-162X, 3 p.Article

Minocycline induced autoimmune disease in rheumatoid arthritis : A missed diagnosis?MARZO-ORTEGA, Helena; MISBAH, Siraj; EMERY, Paul et al.Journal of rheumatology. 2001, Vol 28, Num 2, pp 377-378, issn 0315-162XConference Paper

Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatmentEMERY, Paul.Rheumatology (Oxford. Print). 2012, Vol 51, issn 1462-0324, v22-v30, SUP5Article

Autologous blood stem cell transplantation as therapy for autoimmune diseasesBINGHAM, Sarah J; SNOWDEN, John A; EMERY, Paul et al.Annals of medicine (Helsinki). 2000, Vol 32, Num 9, pp 615-621, issn 0785-3890Article

Development of psoriasis after B Cell depletion with rituximabDASS, Shouvik; VITAL, Edward M; EMERY, Paul et al.Arthritis and rheumatism. 2007, Vol 56, Num 8, pp 2715-2718, issn 0004-3591, 4 p.Article

Combination disease-modifying antirheumatic drug therapy in rheumatoid arthritisPINCUS, Theodore; BREEDVELD, Ferdinand C; EMERY, Paul et al.Clinical and experimental rheumatology (Testo stampato). 1999, Vol 17, Num 6, issn 0392-856X, 124 p., SUP18Serial Issue

Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: A clinical and magnetic resonance imaging studyMARZO-ORTEGA, Helena; MCGONAGLE, Dennis; O'CONNOR, Philip et al.Arthritis and rheumatism. 2001, Vol 44, Num 9, pp 2112-2117, issn 0004-3591Article

Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexateO'DELL, J. R.Clinical and experimental rheumatology (Testo stampato). 1999, Vol 17, Num 6, pp S.53-S.58, issn 0392-856X, SUP18Article

Combination DMARD treatment with parenteral gold and methotrexateRAU, R.Clinical and experimental rheumatology (Testo stampato). 1999, Vol 17, Num 6, pp S.83-S.90, issn 0392-856X, SUP18Article

High dose immunosuppressive therapy and stem cell transplantation in autoimmune and inflammatory diseasesBINGHAM, Sarah J; SNOWDEN, John; MORGAN, Gareth et al.International immunopharmacology. 2002, Vol 2, Num 4, pp 399-414, issn 1567-5769Article

Etanercept and methotrexate combination therapyBANKHURST, A. D.Clinical and experimental rheumatology (Testo stampato). 1999, Vol 17, Num 6, pp S.69-S.72, issn 0392-856X, SUP18Article

Spondylarthrite ankylosante, positivité de HLA-b27 et utilisation des biothérapies = Ankylosing Spondylitis, HLA-b27 positivity and the need for Biologic TherapiesFREESTON, Jane; BARKHAM, Nick; HENSOR, Elizabeth et al.Revue du rhumatisme (Ed. française). 2007, Vol 74, Num 3, pp 232-236, issn 1169-8330, 5 p.Article

Methotrexate and emerging therapiesKREMER, J. M.Clinical and experimental rheumatology (Testo stampato). 1999, Vol 17, Num 6, pp S.43-S.46, issn 0392-856X, SUP18Article

Effect of intra-articular corticosteroid injections and inflammation on periarticular and generalised bone loss in early rheumatoid arthritisHAUGEBERG, Glenn; MORTON, Sarah; EMERY, Paul et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 1, pp 184-187, issn 0003-4967, 4 p.Article

Reporting of long-term extension studies: lack of consistency calls for consensusBUCH, Maya H; ALETAHA, Daniel; EMERY, Paul et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 6, pp 886-890, issn 0003-4967, 5 p.Article

Longterm Safety, Efficacy, and Inhibition of Structural Damage Progression Over 5 Years of Treatment with Abatacept in Patients with Rheumatoid Arthritis in the Abatacept in Inadequate Responders to Methotrexate TrialKREMER, Joel M; PETERFY, Charles; RUSSELL, Anthony S et al.Journal of rheumatology. 2014, Vol 41, Num 6, pp 1077-1087, issn 0315-162X, 11 p.Article